The conference gathered leading specialists such as Rosanna Zhang, Vice President of ACROBiosystems; Li Liang, Associate Professor at the Southern University of Science and Technology (SUSTech); ...

BASEL, Switzerland, March 30, 2023 /PRNewswire/ -- ACROBiosystems has begun to narrow its focus into helping accelerate the process between preclinical, clinical and commercialization. With over 10 ...

In this interview, Dr. Yinan Jiang discusses ACROBiosystems' efforts in the fight against COVID-19 and the search for a vaccine How has ACROBiosystems been involved in the fight against COVID-19?

ACROBiosystems, through ACRO Certify and under its Aneuro brand, recently announced the launch of in vivo electrophysiology solutions for neuroscience research with Diagnostic Biochips. Together, the ...

BASEL, Switzerland, June 7, 2023 /PRNewswire/ -- Cell and gene therapy (CGT) is a cutting-edge therapy that combats cancer by bolstering the immune system through stem cell infusions or modified ...

The right reagents and processes help scientists optimize and standardize T cell therapy manufacturing, from discovery to clinic. See how the BD FACSDiscover™ A8 Cell Analyzer uses real-time imaging ...

Explore the SZ:301080 financials. Find the Acrobiosystems financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers from key ...

TOKYO, Oct. 10, 2025 /PRNewswire/ -- ACROBiosystems, together with Leica Biosystems, Molecular Devices, and Leica Microsystems, hosted the OrganoAsia 2025-The Frontier of Organoid Science in Beijing.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

- Leading Scientists from China, Japan and South Korea Convene to Drive Organoid Research and Commercialization Rosanna Zhang, Vice President of ACROBiosystems, discussed innovative uses of organoids ...

Acrobiosystems Co.,Ltd. engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific ...

- Leading Scientists from China, Japan and South Korea Convene to Drive Organoid Research and Commercialization Li Liang's team at the SUSTech School of Medicine established a biobank of ...